August 29th 2025
This week, expert insights highlighted progress in reducing C difficile with electronic hand hygiene monitoring, advancing HIV prevention with lenacapavir, updating COVID-19 vaccines for high-risk groups, and more.
Head-to-Head Comparison of Treatments for Recurrent C difficile Infection
November 14th 202417 randomized controlled trials involving 4,148 patients assessed the efficacy of various treatments, finding that fecal microbiota transplantation via the lower gastrointestinal route was the most effective.
Read More
Due to FDA Policy Change, Fecal Microbiota Transplants Are in a Tenuous Position
November 13th 2024The country’s largest fecal distributor, OpenBiome, could be prevented from offering the product next year if the FDA does not approve the product used for fecal microbiota transplants to treat fulminant C difficile.
Watch
Top 5 Infectious Disease New Stories Week of November 2-8
November 9th 2024From improving infection control and antibiotic stewardship, identifying RT 027 as a risk factor for vancomycin resistance in C diff, developing a universal flu vaccine, better management for drug-resistant pathogens, and more.
Read More
Top 5 Infectious Disease News Stories Week Of October 18-25
October 26th 2024Experts highlighted research showing that even mild COVID can result in cognitive impairment including brain fog and IQ decline, the FDA approved Pfizer's RSV vaccine for adults aged 18 to 59, E coli outbreak linked to McDonald's Quarter Pounders, and more.
Read More
Targeted Prophylaxis Reduces Hospital-Onset C difficile Infections in High-Risk Patients
October 22nd 2024The STOP-CDI intervention presented by Matthew J.Ziegler, MD MSCE revealed using prophylactic enteral vancomycin, significantly reduced hospital-onset C difficile infections among immunocompromised patients.
Watch
Getting Patients Involved in C diff Advocacy, Treatment Guidelines
October 18th 2024Peggy Lillis Foundation CEO Christian Lillis believes patients need a seat at the table so he is advocating for past patients to become ambassadors to be a voice to help shape treatment and also continue to raise awareness about the infection.
Watch
Top 5 Infectious Disease News Stories Week of September 27-October 4
October 5th 2024Healthcare workers receiving additional COVID-19 vaccine doses had fewer ongoing symptoms, a new test differentiates bacterial from viral infections, CDC reports 10 deaths linked to ongoing listeria outbreak, and more this week from Contagion.
Read More
Top 5 Infectious Disease News Stories Week of September 20-27
September 28th 2024This week, a push for better care standards for C difficile, a survey shows low vaccination rates for respiratory viruses among Americans, Georgia achieves a reduction in chronic hepatitis C infections through collaborative efforts, and more.
Read More
Investigational C Diff Therapy Shows Favorable Microbiome Characteristics, Phase 3 Trial Planned
Published: September 27th 2024 | Updated: September 27th 2024The latest data highlight ibezapolstat’s effects on gut microbiome health and systemic exposure, crucial for CDI treatment, while also indicating its potential against Bacillus anthracis, prompting plans for a bioterrorism development initiative.
Read More
Advocating for Better Regulatory Rules and Standard of Care for C difficile
September 25th 2024Maryann Webb’s harrowing, personal experience with C diff, along with her professional work with federal agencies has prepared her for a life in advocacy with the Peggy Lillis Foundation. She wants to see the fecal microbiota transplant become more accessible and is working with Congress to make the infection a notifiable infectious disease.
Watch
Understanding the Symbiotic Relationship of Biofilms and Vancomycin
September 23rd 2024A new study looked at Bacteroides thetaiotaomicron and C difficile infection (CDI) and their formation of symbiotic biofilms in the antibiotic's environment, and underscore the complexity of CDI prevention and the importance of considering gut microbiomes in treatment strategies.
Read More
Top 5 Infectious Disease News Stories Week of September 13-September 20
September 21st 2024Adults with type 2 diabetes taking metformin have a 13% to 21% lower risk of developing Long COVID or dying from COVID-19, recent analyses question the effectiveness of nirmatrelvir/ritonavir and molnupiravir against new variants, and more this week from Contagion.
Read More
Managing C. difficile Infections in the Clinic
Focusing on the treatment of patients with C. difficile infections, Carl V. Crawford, MD, provides clinical insights on medication tapering practices and therapies being utilized by clinicians.
Watch
Factors Contributing to C. difficile Infection Recurrence
Matthew D. Sims, MD, PhD, FACP, FIDSA, discuss how antibiotics do not completely eliminate C. difficile infections, the drivers of recurrence, and new treatments that are addressing eubiosis and C. difficile spores.
Watch